On October 16, 2023, Aligos Therapeutics Entered Into Settlement Agreement With Janssen Biotech Providing For Resolution Of Previously Disclosed Action Brought By Janssen Alleging Breach Of Contract Aligos CEO, Others
8-k - On October 16, 2023, Aligos Therapeutics, Inc. (the “Company”) entered into a settlement agreement (the “Settlement Agreement”) withJanssen Biotech, Inc. (successor in interest to Janssen